Proscillaridin

DB13307ExperimentalSmall molecule

Proscillaridin is a cardiac glycoside that is derived from plants of the genus Scilla and in Drimia maritima (Scilla maritima). Studies suggest the potential cytotoxic and anticancer property of proscillaridin,... Studies suggest the potential cytotoxic and anticancer property of proscillaridin, based on evidence of the drug potently disrupting topoisomerase I and II activity at nanomolar drug concentrations and triggering cell death and blocking cell proliferation...

Formula / weight: C₃₀H₄₂O₈ · 530.658 g/mol (avg)
Code names: A-32686

Resolves to

Compound

UNIIKC6BL281ENCAS466-06-8ChEMBLCHEMBL600325ChEBI32065PubChem5284613

Clinical / RWD

RxNorm8795ATCC01AB01ATCC01AB51

Structure

InChIKeyMYEJFUXQJGHEQK-ALRJYLEOSA-NSMILES

[H][C@@]1(CC[C@]2(O)[C@]3([H])CCC4=C[C@]([H])(CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@]1([H])O[C@@]([H])(C)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O)C1=COC(=O)C=C1

Targets

P22303ACHE

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

366Drug interactionsStructured to mechanism, not free text

2ATC codesIncluding every combination product, plus 14 drug categories

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Proscillaridin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account